跳至主要内容
临床试验/CTRI/2024/02/062297
CTRI/2024/02/062297尚未招募2/3 期

Randomised Controlled Clinical Trial Study To Compare The Efficiency Of Yashtimadhu Kwath With Vasadi Kwath In Management Of Pandu (Iron Deficiency Anaemia)

Tilak Ayurved Mahavidyalaya,1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年2月10日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
80
试验地点
1
主要终点
Minimum 50% increase in Hb should be observed after the completion of the trial in 60 days

研究概览

简要总结

Anaemia is the most common disorder of blood which affecting about a quarter of people globally. Iron deficiency anaemia is more common is females than males and children, womens of reproductive age group are more common.

Prevalnce of anaemia among women of reproductive age in India is 52% . Yashtimadhu Kwath is choice of drug in pandu(Iron Deficiency anaemia) As it contains Yashtiadhu bharad, which helps to reduce the symptoms of pandu, by its properties like boosting immunity, enhances complexion and mosturizes skin it pacifies pitta, vat and vitiated rakta. enriched with such properties helps to  heal injuries, relieve swelling, works as antidote as a poison.Subjecrive Parameters fot measurements - 1) Panduta 2) shirshoola 3) hrutaspandan 4) Shwas .overall assessment of results will be made by considering the collective effect on all the parameters and scoring criteria.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 49.00 Year(s)(—)
性别
Female

入选标准

  • Women of reproductive age group of 15 to 49 years patients diagnosed with iron deficiency anaemia patients having symptoms of panduta, dourbalya, shwas,hritspandan, akshi koot shoth patients having haemoglobin less than 12.

排除标准

  • patients having haemoglobin less than 7 patient suffering from haematological disorder,gynacological diseases and systemic disorders pregnant females and lactating mothers.

结局指标

主要结局

Minimum 50% increase in Hb should be observed after the completion of the trial in 60 days

时间窗: Baseline, 15th day, 30th day, 45th day, 60th day

次要结局

  • recurrence of pallor,generalized weakness, dyspnoea,giddines(60 days)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Sneha Santosh Karpe

Tilak Ayurved Mahavidyalaya,Pune

研究点 (1)

Loading locations...

相似试验

A Clinical study to evaluate effect of single... | 临床试验